Speakers
Lori Panther
Vice President, Clinical Development, Infectious Diseases
Moderna, Inc
Day One
Wednesday July 14 2021
10:40 am | Live Panel Q&A – Ask Speakers your Burning Questions
9:25 am | Messenger RNA (mRNA) Vaccine Against Cytomegalovirus (CMV) Infection: Phase 2 Interim Data
Jacob Becraft
Chief Scientific Officer & Co-Founder
Strand Therapeutics Inc
Day Two
Thursday July 15 2021
12:00 pm | Panel Discussion: On the Horizon: What is the Future of mRNA Treatments?
Daniel Griffith Anderson
Professor of Chemical Engineering
Institute for Medical Engineering and Science, Koch Institute for Integrative Cancer Research at MIT
Delivery & Manufacturing Focus Day
Tuesday July 13 2021
12:00 pm | Panel Discussion: Debating Between Techniques & Strategies for Optimized Delivery of mRNA Treatments
11:00 am | Live Panel Q&A – Ask Speakers your Burning Questions
9:00 am | Discussing Next Generation Delivery Techniques & Platforms for Highly Effective Delivery of mRNA
Laura Sepp-Lorenzino
Chief Scientific Officer
Intellia Therapeutics
Day Two
Thursday July 15 2021
4:45 pm | Live Panel Q&A – Ask Speakers your Burning Questions
3:55 pm | Transforming Medicine: In Vivo Therapeutic Genome Editing via Transient Expression of CRISPR/Cas9
Andreas Kuhn
Senior Vice President RNA Biochemistry & Manufacturing
BioNTech GmbH
Day One
Wednesday July 14 2021
10:40 am | Live Panel Q&A – Ask Speakers your Burning Questions
9:00 am | Learnings from the Speedy Development of an mRNA-Based COVID-19 Vaccine
Russell Johnson
Local Head Basic Pharmaceutical Sciences
Drug Product, GSK Vaccines
Day One
Wednesday July 14 2021
9:50 am | Pharmacology of Optimal mRNA Therapies for Infectious Disease Considering Safety, Efficacy & Translatability
10:40 am | Live Panel Q&A – Ask Speakers your Burning Questions
Delivery & Manufacturing Focus Day
Tuesday July 13 2021
11:00 am | Live Panel Q&A – Ask Speakers your Burning Questions
Allison August
Vice President, Clinical Development, Infectious Diseases
Moderna, Inc
Day Two
Thursday July 15 2021
2:50 pm | Live Panel Q&A – Ask Speakers your Burning Questions
12:00 pm | Panel Discussion: On the Horizon: What is the Future of mRNA Treatments?
2:00 pm | Results of A Phase 1 Trial Demonstrating mRNA Can Encode & Produce Potentially Therapeutic Levels of a Monoclonal Antibody with Neutralizing Activity Against Chikungunya Virus
Norman Begg
Independent Vaccine Consultant, Former Chief Medical Officer
GSK Vaccines
Day Two
Thursday July 15 2021
12:00 pm | Panel Discussion: On the Horizon: What is the Future of mRNA Treatments?
Venkata R Krishnamurthy
Director & Senior Advisor
Eli Lilly & Company
Day One
Wednesday July 14 2021
5:00 pm | Chair’s Closing Remarks
4:50 pm | Live Panel Q&A – Ask Speakers your Burning Questions
3:20 pm | Live Panel Q&A - Ask Speakers your Burning Questions!
1:15 pm | Live Panel Q&A – Ask Speakers your Burning Questions
10:40 am | Live Panel Q&A – Ask Speakers your Burning Questions
8:50 am | Chair’s Opening Remarks
Delivery & Manufacturing Focus Day
Tuesday July 13 2021
12:00 pm | Panel Discussion: Debating Between Techniques & Strategies for Optimized Delivery of mRNA Treatments
Tasuku Kitada
Co-Founder, Director, President, & Head of R&D
Strand Therapeutics
Day One
Wednesday July 14 2021
3:20 pm | Live Panel Q&A - Ask Speakers your Burning Questions!
2:30 pm | Overview of Current Successes & Landscape of Clinical Data for mRNA Oncology Treatments
Lusong Luo
Senior Vice President, External Innovation
BeiGene
Day Two
Thursday July 15 2021
12:00 pm | Panel Discussion: On the Horizon: What is the Future of mRNA Treatments?
Carsten Rudolph
Managing Director & Chief Scientific Officer
Ethris GmbH
Day Two
Thursday July 15 2021
10:40 am | Live Panel Q&A - Ask Speakers your Burning Questions
9:25 am | Immuno-Modulation & mRNA-based Protein Replacement Therapy Programs for Treatment of Pulmonary Disease
Lior Zangi
Associate Professor
Icahn School of Medicine at Mount Sinai
Day Two
Thursday July 15 2021
10:40 am | Live Panel Q&A - Ask Speakers your Burning Questions
9:00 am | mRNA-Based Approach for Treating Ischemic Heart Disease
Joseph Barberio
Director, mRNA Process Development
Strand Therapeutics Inc
Delivery & Manufacturing Focus Day
Tuesday July 13 2021
3:30 pm | Panel Discussion: Delving into Optimized the Process Development to Support mRNA Therapeutic Development & Assess Clinical Translation Efficiency
Kristy Wood
Senior Director, Technical Operations
Intellia Therapeutics
Delivery & Manufacturing Focus Day
Tuesday July 13 2021
3:30 pm | Panel Discussion: Delving into Optimized the Process Development to Support mRNA Therapeutic Development & Assess Clinical Translation Efficiency
2:30 pm | A Platform Manufacturing Approach to CRISPR/Cas9 Genome Editing Therapeutics
Jay Sarkar
Co-founder & Chief Technology Officer
Turn Biotechnologies
Day Two
Thursday July 15 2021
10:40 am | Live Panel Q&A - Ask Speakers your Burning Questions
9:50 am | mRNA Applications in Epigenetic Therapy
Mouhannad Jumaa
Senior Vice President of Pharmaceutical Development
Turn Biotechnologies
Delivery & Manufacturing Focus Day
Tuesday July 13 2021
12:00 pm | Panel Discussion: Debating Between Techniques & Strategies for Optimized Delivery of mRNA Treatments
Anthony Partridge
Senior Principal Scientist
MSD Singapore
Day One
Wednesday July 14 2021
4:50 pm | Live Panel Q&A – Ask Speakers your Burning Questions
4:00 pm | Exquisitely Specific Anti-KRAS Biodegraders – Informing Cellular Prevalence of Nucleotide-Loaded States
Ali Miserez
Professor
Nanyang Technological University, Singapore
Delivery & Manufacturing Focus Day
Tuesday July 13 2021
11:00 am | Live Panel Q&A – Ask Speakers your Burning Questions
9:30 am | Biomimetic Peptide Coacervates as Safe & Efficient Delivery Vehicles of Macromolecular Therapeutics
Shu-Bing Qian
Professor
Cornell University
Day One
Wednesday July 14 2021
3:20 pm | Live Panel Q&A - Ask Speakers your Burning Questions!
2:55 pm | Targeting Cancer Using Artificial mRNA Treatments
Vittorio Sebastiano
Assistant Professor OBGyN
Stanford University
Day Two
Thursday July 15 2021
4:45 pm | Live Panel Q&A – Ask Speakers your Burning Questions
4:20 pm | Reversing the Irreversible: Epigenetic Reprogramming of Aging Through mRNAs
Gal Cafri
Immunotherapy & Genetic Engineering Group Leader
Sheba Medical Center
Day One
Wednesday July 14 2021
4:50 pm | Live Panel Q&A – Ask Speakers your Burning Questions
4:25 pm | Insights from the Development of a Personalized mRNA Vaccine for Gastrointestinal Cancer Patients
Day Two
Thursday July 15 2021
12:00 pm | Panel Discussion: On the Horizon: What is the Future of mRNA Treatments?
Steve Hughes
Chief Medical Officer
Arcturus Therapeutics
Day One
Wednesday July 14 2021
1:15 pm | Live Panel Q&A – Ask Speakers your Burning Questions
12:00 pm | LUNAR®-COV19: The Arcturus Therapeutics SARS-CoV-2 mRNA Vaccine Candidate
Yizhou Dong
Associate Professor
The Ohio State University
Day One
Wednesday July 14 2021
12:50 pm | Novel Delivery Appriaches to Enhance Stability, Effectivity & Safety of mRNA Therapies
1:15 pm | Live Panel Q&A – Ask Speakers your Burning Questions
Nicolas Havelange
CMC Lead
CEPI
Delivery & Manufacturing Focus Day
Tuesday July 13 2021
3:30 pm | Panel Discussion: Delving into Optimized the Process Development to Support mRNA Therapeutic Development & Assess Clinical Translation Efficiency
2:00 pm | Deliberating Novel Delivery & Advanced Manufacturing of mRNA Therapies to Optimize Commercialization
Pooja Tiwari
Associate Scientist
Emory School of Medicine
Day One
Wednesday July 14 2021
1:15 pm | Live Panel Q&A – Ask Speakers your Burning Questions
12:25 pm | mRNA Therapeutics for Infectious Diseases: The CRISPR-Cas13 Way
Arpan Desai
Associate Director, Nucleic Acid Therapeutics, Pharmaceutical Sciences, R&D
AstraZeneca
Day Two
Thursday July 15 2021
2:50 pm | Live Panel Q&A – Ask Speakers your Burning Questions
4:45 pm | Live Panel Q&A – Ask Speakers your Burning Questions
10:40 am | Live Panel Q&A - Ask Speakers your Burning Questions
Katarina Stenklo
Enterprise Solutions Commercial Activation Leader
Cytiva
Day Two
Thursday July 15 2021
2:50 pm | Live Panel Q&A – Ask Speakers your Burning Questions
2:25 pm | Flexibility is Key: Addressing Vaccine Demand with Rapid Deployment of mRNA Manufacturing
Jimmy Chu
Scientist II, mRNA Process Development
bluebird bio
Delivery & Manufacturing Focus Day
Tuesday July 13 2021
3:30 pm | Panel Discussion: Delving into Optimized the Process Development to Support mRNA Therapeutic Development & Assess Clinical Translation Efficiency
3:00 pm | Process Development – From Design & Development to Technology Transfer of mRNA Drug Substance Manufacturing Process
James Sullivan
Senior Vice President Pulmonary Research
Translate Bio
Day Two
Thursday July 15 2021
3:30 pm | Advancing Delivery Of mRNA Therapeutics For The Treatment Of Genetic Diseases
4:45 pm | Live Panel Q&A – Ask Speakers your Burning Questions
Rok Sekirnik
Head Process Development mRNA/ pDNA
BIA Separations
Day One
Wednesday July 14 2021
10:15 am | From E. coli to mRNA Drug Substance – Development of Analytical and Purification Tools for a Scalable mRNA Production Process
10:40 am | Live Panel Q&A – Ask Speakers your Burning Questions
Dushyant Varshney
Executive Vice President & Chief Technology Officer
Arcturus Therapeutics
Delivery & Manufacturing Focus Day
Tuesday July 13 2021
10:30 am | Commercialization and Technology Transfer of mRNA Therapeutics and Lyophilized Vaccines
11:00 am | Live Panel Q&A – Ask Speakers your Burning Questions
Aalok Shah
Associate Director, Formulation Design
Strand Therapeutics Inc.
Delivery & Manufacturing Focus Day
Tuesday July 13 2021
12:00 pm | Panel Discussion: Debating Between Techniques & Strategies for Optimized Delivery of mRNA Treatments
Anthony Rizzo
Chief Commercial Officer
Cold Chain Technologies, LLC
Day Two
Thursday July 15 2021
10:15 am | Managing Temperature-Sensitive Requirements for the Transportation and Storage of mRNA Biopharmaceuticals
10:40 am | Live Panel Q&A - Ask Speakers your Burning Questions
Cytiva
BIA Separations
Uwe Gottschalk
Chief Scientific Officer
Lonza
Delivery & Manufacturing Focus Day
Tuesday July 13 2021
12:00 pm | Panel Discussion: Debating Between Techniques & Strategies for Optimized Delivery of mRNA Treatments
Michael Buschmann
Co-founder & Chief Scientific Officer
AexeRNA Therapeutics
Delivery & Manufacturing Focus Day
Tuesday July 13 2021
10:00 am | The AexLNPTM System: Next Generation Lipid Nanoparticles Unlocking mRNA Therapeutic Opportunities
11:00 am | Live Panel Q&A – Ask Speakers your Burning Questions
